INS and metabolic disease: Similarly, in metabolic disorders such as diabetes and obesity, genetic predispositions influence drug metabolism, insulin sensitivity, and lipid regulation, necessitating precision-based interventions to optimize therapeutic responses and prevent disease progression [2].